EGFR and neoplasm: Interestingly, this inhibition only occurred in cetuximab-sensitive but not in cetuximab-resistant HNSCC cell lines, data that argues in favor of a metabolic immunoescape mechanism to EGFR inhibition of HNSCC cells mediated by lactate acidification of the tumor milieu (Lu et al., 2013).